By Lana Barhum November 16, 2022 Medically reviewed by Susan Russell, MD Interstitial lung disease (ILD) includes more than 200 conditions that cause inflammation and scarring of lung tissue.1 The damage done by interstitial lung […]
Vaccine-induced interstitial lung disease: a rare reaction to COVID-19 vaccination
Alison M DeDent, Erica Farrand Correspondence to Dr Alison M DeDent, 513 Parnassus Ave, HSE 1314, Box 0111, University of California San Francisco, San Francisco, California CA 94143, USA; alison.dedent@ucsf.edu The COVID-19 Vaccine: […]
Even mild cases of COVID-19 can lead to long-term health problems, study finds
A new study published in the journal Nature Medicine has found that even mild cases of COVID-19 can lead to an increased risk of long-term health problems two years later. […]
How Covid-19 damages lungs explained
Authors: mINT oCTOBER 31, 2022 sYNOPSIS SARS-CoV-2 is the third novel coronavirus to cause human outbreaks in the 21st century, following SARS-CoV in 2003 and MERS-CoV in 2012. Covid-19: The […]
Is COVID-19 a Respiratory or Vascular Disease?
Authors: Medically reviewed by Meredith Goodwin, MD, FAAFP — By S. Behring Health Line COVID-19 is normally associated with the lungs and respiratory system. Most people think of symptoms such as coughing and shortness […]
What You Should Know About Long-Haul COVID
Authors: KELSEY KLOSS PUBLISHED 05/03/22 Here’s what research says about how long COVID lung disease, mental health, brain fog, and more may impact people who are immunocompromised. Throughout the pandemic, […]
1000 Peer Reviewed Studies Questioning Covid-19 Vaccine Safety
Peer Reviewed Medical Papers Submitted To Various Medical Journals, Evidencing A Multitude Of Adverse Events In Covid-19 Vaccine Recipients. The list includes studies published as of January 20, 2022 concerning […]
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Authors.Maximilian Ackermann, M.D., Stijn E. Verleden, Ph.D., Mark Kuehnel, Ph.D., Axel Haverich, M.D., Tobias Welte, M.D., Florian Laenger, M.D., Arno Vanstapel, Ph.D., Christopher Werlein, M.D., Helge Stark, Ph.D., Alexandar Tzankov, M.D., William W. Li, M.D., Vincent W. Li, M.D., et al. July […]
Endothelial thrombomodulin downregulation caused by hypoxia contributes to severe infiltration and coagulopathy in COVID-19 patient lungs
Authors: Taejoon Won, Megan K. Wood, David M. Hughes, Monica V. Talor, Zexu Ma Jowaly Schneider, et al. Published:January 12, 2022DOI:https://doi.org/10.1016/j.ebiom.2022.103812 Background Thromboembolism is a life-threatening manifestation of coronavirus disease […]
Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people
Julia Hippisley-Cox1, Duncan Young2,3, Carol Coupland4, Keith M Channon5, Pui San Tan6, David A Harrison7, Kathryn Rowan8, Paul Aveyard6, Ian D Pavord9, Peter J Watkinson5,10 Correspondence to Prof Julia Hippisley-Cox, Primary Care Health Sciences, University of Oxford, Oxford OX1 […]